CL2012003209A1 - Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico. - Google Patents
Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico.Info
- Publication number
- CL2012003209A1 CL2012003209A1 CL2012003209A CL2012003209A CL2012003209A1 CL 2012003209 A1 CL2012003209 A1 CL 2012003209A1 CL 2012003209 A CL2012003209 A CL 2012003209A CL 2012003209 A CL2012003209 A CL 2012003209A CL 2012003209 A1 CL2012003209 A1 CL 2012003209A1
- Authority
- CL
- Chile
- Prior art keywords
- pentoxifylline
- nanoparticles
- plga
- lactic
- poly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
Método de síntesis de nanopartículas de ácido poli (láctico-glicólico) (PLGA) con pentoxifilina; composición farmacéutica que comprende nanopartículas de PLGA con pentoxifilina encapsulada; y uso de nanopartículas de PLGA cargadas con pentoxifilina en el tratamiento del alivio y prevención del dolor crónico.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2012003209A CL2012003209A1 (es) | 2012-11-16 | 2012-11-16 | Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico. |
US14/443,260 US20150283095A1 (en) | 2012-11-16 | 2013-11-15 | Nanoparticles with biodegradable and biocompatible polymer plga, loaded with the drug for human use pentoxifylline |
MX2015006187A MX2015006187A (es) | 2012-11-16 | 2013-11-15 | Nanoparticulas con polimero biodegradable y biocompatible acido poli(lactico-glicolico)(plga) cargadas con el farmaco de uso humano pentoxifilina. |
BR112015011294A BR112015011294A8 (pt) | 2012-11-16 | 2013-11-15 | nanopartículas com polímero biodegradável e biocompatível plga carregadas com o fármaco pentoxifilina de uso humano e uso destas |
PCT/CL2013/000084 WO2014075203A1 (es) | 2012-11-16 | 2013-11-15 | Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2012003209A CL2012003209A1 (es) | 2012-11-16 | 2012-11-16 | Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012003209A1 true CL2012003209A1 (es) | 2013-04-19 |
Family
ID=50730445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012003209A CL2012003209A1 (es) | 2012-11-16 | 2012-11-16 | Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico. |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150283095A1 (es) |
BR (1) | BR112015011294A8 (es) |
CL (1) | CL2012003209A1 (es) |
MX (1) | MX2015006187A (es) |
WO (1) | WO2014075203A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8153435B1 (en) | 2005-03-30 | 2012-04-10 | Tracer Detection Technology Corp. | Methods and articles for identifying objects using encapsulated perfluorocarbon tracers |
WO2023056372A1 (en) * | 2021-09-29 | 2023-04-06 | Oncour Pharma, Inc. | Negatively charged particles for the treatment of inflammation-related burn injuries |
CN114870023A (zh) * | 2022-05-12 | 2022-08-09 | 成都市第三人民医院 | 一种缓释的视神经保护药物纳米合成材料及其制备方法和应用 |
CN116585488B (zh) * | 2023-05-08 | 2024-02-23 | 广东省第二人民医院(广东省卫生应急医院) | 一种罗哌卡因纳米载药材料及其制备方法 |
CN116869968B (zh) * | 2023-09-07 | 2023-11-24 | 四川大学 | 一种靶向大脑和脑胶质瘤的纳米粒及其合成方法、应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532003A (en) * | 1994-01-18 | 1996-07-02 | Alza Corporation | Pentoxifylline therapy |
DE102006013531A1 (de) * | 2006-03-24 | 2007-09-27 | Lts Lohmann Therapie-Systeme Ag | Polylactid-Nanopartikel |
WO2008105773A2 (en) * | 2006-03-31 | 2008-09-04 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
KR100853309B1 (ko) * | 2006-11-01 | 2008-08-20 | 나재운 | 시프로플록사신이 담지된 폴리락타이드글리콜라이드공중합체의 서방출 및 생분해성 나노입자 및 그 제조방법 |
US20120238590A1 (en) * | 2010-09-13 | 2012-09-20 | Tenera Therapeutics, LLC Delaware | Compositions for treating cancer-related fatigue and methods of screening thereof |
WO2013185032A1 (en) * | 2012-06-07 | 2013-12-12 | President And Fellows Of Harvard College | Nanotherapeutics for drug targeting |
-
2012
- 2012-11-16 CL CL2012003209A patent/CL2012003209A1/es unknown
-
2013
- 2013-11-15 MX MX2015006187A patent/MX2015006187A/es unknown
- 2013-11-15 BR BR112015011294A patent/BR112015011294A8/pt not_active Application Discontinuation
- 2013-11-15 WO PCT/CL2013/000084 patent/WO2014075203A1/es active Application Filing
- 2013-11-15 US US14/443,260 patent/US20150283095A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150283095A1 (en) | 2015-10-08 |
BR112015011294A2 (pt) | 2017-07-11 |
WO2014075203A8 (es) | 2014-07-17 |
BR112015011294A8 (pt) | 2019-10-22 |
MX2015006187A (es) | 2015-08-10 |
WO2014075203A1 (es) | 2014-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
CR20150386A (es) | Composiciones de nanoparticulas de albumina y paclitaxel | |
CY1122098T1 (el) | Παραγωγα ισοχρωμενιου ως αναστολεις κινασων φωσφοϊνοσιτιδης-3 | |
CL2014002726A1 (es) | Compuestos derivados de pirrolopirimidina y purina; composicion farmaceutica; utiles en el tratamiento del cancer (div. sol. 566-14). | |
CL2015003395A1 (es) | Derivados pirazolopirrolidina y su uso en el tratamiento de la enfermedad | |
MX2020010412A (es) | Inhibidores de tirosina quinasa de bruton. | |
CL2015002658A1 (es) | Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio | |
PH12015500115A1 (en) | Glucagon analogues | |
HK1221178A1 (zh) | 卡博替尼劑型及其在癌症治療中的使用 | |
CL2014001829A1 (es) | Compuestos derivados de indolizina; procedimiento de preparación; composiciones farmacéuticas que los contienen y uso en el tratamiento del cancer. | |
WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
NI201500067A (es) | Compuestos de pirrolopirimidina como inhibidores de quinasa | |
EP3052476A4 (en) | Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease | |
MX2015009105A (es) | Composiciones en solucion solida y su uso en inflamacion cronica. | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
GB201411465D0 (en) | Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer | |
ECSP14024526A (es) | Derivados bicíclicos de pirazinona | |
ECSP14017586A (es) | Derivados de tetrahidro-quinazolinona | |
CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
MX2015009045A (es) | Composiciones y metodos para tratar el dolor severo. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
CL2012003209A1 (es) | Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico. | |
BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
WO2014153385A3 (en) | Methods of treating metabolic disorders |